Verition Fund Management’s SBC Medical Group SBC Stock Holding History

Verition Fund Management’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-182,682	Closed	-$1.95M	–	3014
2023 Q4	$1.95M	Hold	182,682	–	–	0.02%	856
2023 Q3	$1.95M	Hold	182,682	–	–	0.02%	795
2023 Q2	$1.88M	Sell	182,682 -197,000	-52%	-$2.04M	0.03%	694
2023 Q1	$3.96M	Sell	379,682 -510	-0.1%	-$5.27K	0.05%	449
2022 Q4	$3.9M	Buy	380,192 +155,700	+69%	+$1.58M	0.06%	402
2022 Q3	$2.25M	Buy	+224,492	New	+$2.24M	0.03%	829

Other funds holding SBC

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Verition Fund Management's SBC Position: Q1 2024 in Review

Verition Fund Management sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 182,682 shares — an estimated $1.95M sold.

Verition Fund Management first reported a position in SBC in Q3 2022 and held it in 6 quarters. The position peaked at $3.96M in Q1 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

Verition Fund Management reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
Verition Fund Management sold 182,682 SBC Medical Group shares in Q1 2024, an estimated $1.95M.
Verition Fund Management first reported a position in SBC Medical Group in Q3 2022 and held it in 6 quarters.
Verition Fund Management's SBC Medical Group position peaked at $3.96M in Q1 2023.
5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.